Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS). — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(1 site)
United States
Department of Gynecology & Obstetrics, Emory University School of Medicine, Atlanta, Georgia Last updated September 2025